Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

TTelix Pharmaceuticals Ltd

EconomyAI buildoutMarket MapFundsWatchlist
Log in
T

Telix Pharmaceuticals Ltd

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $803.79M. Net result −$7.13M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $803.79M. Running result $803.79M. Revenue: $803.79M.
  • Cost of revenue: −$377.36M. Running result $426.44M.
  • Gross profit: $426.44M. Running result $426.44M.
  • Operating costs: −$396.66M. Running result $29.78M.
  • Operating income: $29.78M. Running result $29.78M.
  • Other expense: −$35.04M. Running result −$5.27M.
  • Pre-tax loss: −$5.27M. Running result −$5.27M.
  • Income tax expense: −$1.86M. Running result −$7.13M.
  • Net loss: −$7.13M. Running result −$7.13M.